Related Experiment Video
Updated: Jun 19, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Rasmussen's encephalitis: update on pathogenesis and treatment.
Pia Bernasconi1, Carlo Antozzi, Tiziana Granata
1Istituto Nazionale Neurologico Carlo Besta, via Celoria 11, 20133 Milan, Italy. pbernasconi@istituto-besta.it
Rasmussen's encephalitis involves immune system activity, potentially perpetuating the disease. While surgery is the only seizure prevention, immunomodulatory treatments show variable efficacy, suggesting a role for immune responses.
Area of Science:
- Neurology
- Immunology
- Pathophysiology
Background:
- Rasmussen's encephalitis is a severe neurological disorder causing intractable epilepsy and unilateral cerebral atrophy.
- Current treatment primarily involves hemispherectomy, a surgical disconnection, to control seizures.
- The disease's etiology is unknown, but recent findings suggest immune system involvement.
Purpose of the Study:
- To explore the role of the immune system in Rasmussen's encephalitis.
- To evaluate the potential of immunomodulatory therapies in managing the disease.
Main Methods:
- Review of laboratory findings indicating immune system involvement.
- Analysis of the efficacy of various immunomodulatory treatments (corticosteroids, plasmapheresis, IVIg, immunosuppressants).
Main Results:
- Laboratory data suggest a link between the immune system and Rasmussen's encephalitis.
- Immunomodulatory treatments demonstrated variable efficacy in patients.
- The immune system may play a role in disease perpetuation.
Conclusions:
- The immune system is implicated in Rasmussen's encephalitis, potentially in disease perpetuation.
- Further research is needed to determine if immune findings are initiating events or consequences.
- Immunomodulatory therapies offer a potential avenue for treatment, albeit with variable success.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Bacterial Meningitis II: Pathophysiology
Rocky Mountain Spotted Fever
Arboviral Encephalitis
Bacterial Meningitis I: Introduction